Multiple sclerosis-associated retroviral agent (MSRV)-stimulated cytokine production in patients with relapsing-remitting multiple sclerosis

被引:34
|
作者
Saresella, M. [2 ]
Rolland, A. [3 ]
Marventano, I. [2 ]
Cavarretta, R. [4 ]
Caputo, D. [4 ]
Marche, P. [3 ]
Perron, H. [5 ]
Clerici, M. [1 ,2 ]
机构
[1] Univ Milan, Dept Biomed Sci & Technol, Chair Immunol, I-20090 Milan, Italy
[2] Don C Gnocchi ONLUS Fdn IRCCS, Lab Mol Med & Biotechnol, I-20148 Milan, Italy
[3] CEA, INSERUM, U548, Lab Immunochim, F-38054 Grenoble, France
[4] Don C Gnocchi ONLUS Fdn, IRCCS, Multiple Sclerosis Unit, I-20148 Milan, Italy
[5] GeNeuro, Geneva, Switzerland
关键词
cytokines; ENV-SU protein; human endogenous retroviruses (HERV); immunology; multiple sclerosis; T lymphocytes; ENVELOPE PROTEIN; MSRV; EXPRESSION; LYMPHOCYTES;
D O I
10.1177/1352458508100840
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Human endogenous retroviruses are suggested to play a pathogenic role in multiple sclerosis (MS); one of such retroviruses, the MS-associated retroviral agent (MSRV) has repeatedly been isolated in MS patients. Objective and methods We analyzed cytokine profiles in MSRV envelope protein (MSRV ENV-SU)stimulated peripheral blood mononuclear cells of 30 relapsing-remitting MS patients with either acute (AMS) (n = 13) or stable (SMS) (n = 17) disease. Results suggest that MSRV ENV-SU induces the production of inflammatory cytokines, including tumor necrosis factor-alpha (P < 0.05) and interferon-gamma (P < 0.004) in AMS patients and of interleukin-10 (P < 0.05), an inflammation-dampening cytokine, in SMS individuals. Conclusions These data strengthen the hypothesis indicating that MSRV could be involved in the pathogenesis of MS. Multiple Sclerosis 2009; 15: 443-447. http://msj.sagepub.com
引用
收藏
页码:443 / 447
页数:5
相关论文
共 50 条
  • [1] Correlation between disease severity and in vitro cytokine production mediated by MSRV (Multiple Sclerosis associated RetroViral element) envelope protein in patients with multiple sclerosis
    Rolland, A
    Jouvin-Marche, E
    Saresella, M
    Ferrante, P
    Cavaretta, R
    Créange, A
    Marche, P
    Perron, H
    JOURNAL OF NEUROIMMUNOLOGY, 2005, 160 (1-2) : 195 - 203
  • [2] Imbalance in T-cell and cytokine profiles in patients with relapsing-remitting multiple sclerosis
    Mikulkova, Z.
    Praksova, P.
    Stourac, P.
    Bednarik, J.
    Michalek, J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 300 (1-2) : 135 - 141
  • [3] 25 Hydroxyvitamin D and Cytokine Profile in Patients With Relapsing-Remitting Multiple Sclerosis
    Slavov, Georgi S.
    Manova, Mariya G.
    Kostadinova, Ivanka I.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [4] Cytokine profile in relapsing-remitting multiple sclerosis patients and the association between progression and activity of the disease
    Kallaur, Ana Paula
    Oliveira, Sayonara Rangel
    Colado Simao, Andrea Name
    Delicato De Almeida, Elaine Regina
    Morimoto, Helena Kaminami
    Lopes, Josiane
    De Carvalho Jennings Pereira, Wildea Lice
    Andrade, Renato Marques
    Pelegrino, Larissa Muliterno
    Borelli, Sueli Donizete
    Kaimen-Maciel, Damacio Ramon
    Vissoci Reiche, Edna Maria
    MOLECULAR MEDICINE REPORTS, 2013, 7 (03) : 1010 - 1020
  • [5] Natalizumab in relapsing-remitting multiple sclerosis
    Outteryck, Olivier
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (05) : 471 - 481
  • [6] Depression in relapsing-remitting multiple sclerosis
    Mendes, MF
    Tilbery, CP
    Balsimelli, S
    Moreira, MA
    Barao-Cruz, AM
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2003, 61 (3A) : 591 - 595
  • [7] Relapsing-remitting tumefactive multiple sclerosis
    Selkirk, SM
    Shi, J
    MULTIPLE SCLEROSIS, 2005, 11 (06): : 731 - 734
  • [8] Rituximab for relapsing-remitting multiple sclerosis
    He, Dian
    Guo, Rui
    Zhang, Fubo
    Zhang, Chao
    Dong, Shuai
    Zhou, Hongyu
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [9] Cytokine profile in relapsing-remitting multiple sclerosis patients and the association with the progression and the activity of the disease
    Kallaur, Ana Paula
    Oliveira, Sayonara Rangel
    Colado Simao, Andrea Name
    Delicato de Almeida, Elaine Regina
    Morimoto, Helena Kaminami
    Kaimen-Maciel, Damacio Ramon
    Lopes, Josiane
    de Carvalho Jennings Pereira, Wildea Lice
    Andrade, Renato Marques
    Pelegrino, Larissa Muliterno
    Vissoci Reiche, Edna Maria
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1832 - 1832
  • [10] Natalizumab for relapsing-remitting multiple sclerosis
    Horga, A.
    Tintore, M.
    NEUROLOGIA, 2011, 26 (06): : 357 - 368